After the first heart transplant took place in 1967, the earliest patients were treated like celebrities. Medical knowledge and technology has improved dramatically since then. While heart transplants are still considered a treatment of last resort, they are the gold standard therapy for end-stage heart failure.
“The best thing you can do for a potential heart transplant patient is to help them avoid a transplant,” says Daniel Jacoby, MD, director of the Heart Failure Program at Yale Medicine. However, if a heart transplant is necessary, Yale Medicine is one of the best places to be, Dr. Jacoby says. Yale Medicine cardiologists and surgeons have an extensive track record of outstanding clinical outcomes in conventional operations for heart failure, implantation of mechanical circulatory support devices, and heart transplantation. They are national leaders in both clinical and basic scientific research in areas relevant to heart failure.